1. Utpatel K., Calvisi D.F., Kohler G. et al.Complexity of PEComas: Diagnostic approach, molecular background, clinical management. Pathologe. 2019; 41 (Suppl. 1): 9-19. DOI: 10.1007/s00292-019-0612-5
2. Murad Gutierrez V., Aponte Barrios WO., Romero Enciso J.A. Angiomiolipoma renal: nuevas perspectivas [Renal angiomyolipoma: New perspectives]. Rev. Colomb. Urol. 2016; 25 (1): 16-24. http://doi.org/10.1016Zj.uroco.2015.12.009.
3. Lin L., Li X, Guan H. et al. Renal function, complications, and outcomes of a reduction in tumor size after transarterial embolization for renal angiomyolipomas: a meta-analysis. J. Int. Med. Res. 2019; 47: 1417-1428. DOI: 10.1177/0300060519834447
4. Flum A.S., Hamoui N., Said M.A. et al. Update on the Diagnosis and Management of Renal Angiomyolipoma. J. Urol. 2016; 195 (4, Pt 1): 834-846. http://doi.org/10.1016Zj.juro.2015.07.126.
5. Grassano Y., Rollin P., Hermieu N. et al. Results of active surveillance for sporadic renal angiomyolipomas greater than 4 cm: A pledge for active surveillance. Prog. Urol. 2021; 31 (2): 99-104. DOI: 10.1016/j.purol.2020.08.004
6. Fernandez-Pello S., Hora M., Kuusk T. et al. Management of Sporadic Renal Angiomyolipomas: A Systematic Review of Available Evidence to Guide Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel. Eur. Urol. Oncol. 2020; 3 (1): 57-72. DOI: 10.1016/j.euo.2019.04.005
7. Wang S.F., Lo W.O. Benign Neoplasm of Kidney: Angiomyolipoma. J. Med. Ultrasound. 2018; 26 (3): 119-122. DOI: 10.4103/JMU.JMU_48_18
8. Bhatt J.R., Richard P.O., Kim N.S. et al. Natural History of Renal Angiomyolipoma (AML): Most Patients with Large AMLs >4 cm Can Be Offered Active Surveillance as an Initial Management Strategy. Eur. Urol. 2016; 70 (1): 85-90. DOI: 10.1016/j.eururo.2016.01.048
9. Restrepo J.C.A., Millan D.A.C., Sabogal C.A.R. et al. New Trends and Evidence for the Management of Renal Angiomyolipoma: A Comprehensive Narrative Review of the Literature. J. Kidney Cancer VHL. 2022; 9 (1): 33-41. DOI: 10.15586/jkcvhl.v9i1.177
10. Jinzaki M., Silverman S.G., Akita H. et al. Diagnosis of Renal Angiomyolipomas: Classic, Fat-Poor, and Epithelioid Types. Semin. Ultrasound CT MR. 2017; 38 (1): 37-46. DOI: 10.1053/j.sult.2016.11.001
11. Murray T., Lee M. Are We Overtreating Renal Angiomyolipoma: A Review of the Literature and Assessment of Contemporary Management and FollowUp Strategies Cardiovasc.Intervent. Radiol. 2018; 41 (4): 525-536. DOI: 10.1007/s00270-017-1862-3
12. Jinzaki M., Silverman S.G., Akita H. et al. Renal angiomyolipoma: a radiological classification and update on recent developments in diagnosis and management. Abdom. Imaging. 2014; 39 (3): 588-604. DOI: 10.1007/s00261-014-0083-3
13. Gandhi S., Pal B., Patel K. et al. Role of 64 slice multidetector computed tomography and angiography to establish relationship between tumor size, aneurysm formation and spontaneous rupture of renal angiomyo-lipomas: Single center experience. Urol. Ann. 2016; 8 (2): 173-177. DOI: 10.4103/0974-7796.172213
14. Lee K., Tsai H., Kao Y. et al. Clinical behavior and management of three types of renal angiomyolipomas. J. Formos Med. Assoc. 2019; 118 (1, Pt 1): 162-169. DOI: 10.1016/j.jfma.2018.02.012
15. Oesterling J., Fishman E., Goldman S., Marshall F. The management of renal angiomyolipoma. J. Urol. 1986; 135 (6): 1121-1124. DOI: 10.1016/s0022-5347(17)46013-7
16. Murray T., Doyle F., Lee M. Transarterial Embolization of Angiomyolipoma: A Systematic Review. J. Urol. 2015; 194 (3): 635-639. DOI: 10.1016/j.juro.2015.04.081
17. Zhong J., Yuan J., Chong V. et al. The clinical application of one-stop examination with 640-slice volume CT for Nutcracker syndrome. PLoS One. 2013; 8 (9): e74365. DOI: 10.1371/journal.pone.0074365
18. McQueen S., Combes A., Benz D. Renal angiomyolipoma: Beyond size criteria for predicting rupture. J. Med. Imaging Radiat. Oncol. 2023; 67 (6): 619-624. DOI: 10.1111/1754-9485.13547
19. Almazedi B., Stubbs C. Renal angiomyolipoma: from imaging to intervention. Clin. Radiol. 2024; 79 (1): 25-32. DOI: 10.1016/j.crad.2023.09.028
20. Anis O., Rimon U., Ramon J. et al. Selective Arterial Embolization for Large or Symptomatic Renal Angiomyolipoma: 10 Years of Follow-up. Urology. 2020; 135: 82-87. DOI: 10.1016/j.urology.2019
21. Yamakado K., Tanaka N., Nakagawa T. et al. Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture. Radiology. 2002; 225 (1): 78-82. DOI: 10.1148/radiol.2251011477
22. Jung Y., Choi M.J., Kim B.M. et al. Transarterial Embolization for Sporadic Renal Angiomyolipoma: Patient Selection and Technical Considerations for Optimal Therapeutic Outcomes. Taehan Yongsang Uihakhoe Chi. 2022; 83 (3): 559-581. DOI: 10.3348/jksr.2021.0120
23. Liu J., Meng T., Yang X. et al. Spontaneous rupture of renal angiomyolipoma in the third trimester. Taiwan J. Obstet. Gynecol. 2015; 54 (6): 788-790. DOI: 10.1016/j.tjog.2015
24. Lenton J., Kessel D., Watkinson A.F. Embolization of renal angiomyolipoma: immediate complications and long-term outcomes. Clin. Radiol. 2008; 63 (8): 864-870. DOI: 10.1016/j.crad.2008.02.005
25. Bardin F., Chevallier O., Bertaut A. et al. Selective arterial embolization of symptomatic and asymptomatic renal angiomyolipomas: a retrospective study of safety, outcomes and tumor size reduction. Quant. Imaging Med. Surg. 2017; 7 (1): 8-23. DOI: 10.21037/qims.2017.01.02
26. Chan C., Yu S., Yip S., Lee P. The efficacy, safety and durability of selective renal arterial embolization in treating symptomatic and asymptomatic renal angiomyolipoma. Urology. 2011; 77 (3): 642-648. DOI: 10.1016/j.urology.2010.08.040
27. Lin L., Wang C., Pei R. et al. Prophylactic selective arterial embolization for renal angiomyolipomas: efficacy and evaluation of predictive factors of significant shrinkage.Int. Urol. Nephrol. 2018; 50 (10): 1765-1770. DOI: 10.1007/s11255-018-1953-3
28. Chick C.M., Tan B.S., Cheng C. et al. Long-term followup of the treatment of renal angiomyolipomas after selective arterial embolization with alcohol. BJU Int. 2010; 105 (3): 390-394. http://doi.org/10.111Vj.1464-410X.2009.08813.x.
29. Planche O., Correas J.M., Mader B. et al. Prophylactic embolization of renal angiomyolipomas: evaluation of therapeutic response using CT 3D volume calculation and density histograms. J. Vasc.Interv. Radiol. 2011; 22 (10): 1388-1395. DOI: 10.1016/j.jvir.2011.05.016
30. Chen Y., Zhang J., Dai J. et al. Angiogenesis of renal cell carcinoma: perfusion CT findings. Abdom. Imaging. 2010; 35 (5): 622-628. DOI: 10.1007/s00261-009-9565-0
31. Chen C., Kang Q., Xu B. et al. Fat poor angiomyolipoma differentiation from renal cell carcinoma at 320-slice dynamic volume CT perfusion. PLoS One. 2014; 9 (1): e85522. DOI: 10.1371/journal.pone.0085522
32. Mazzei F.G., Mazzei M.A., Cioffi Squitieri N. et al. CT perfusion in the characterisation of renal lesions: an added value to multiphasic CT. Biomed. Res. Int. 2014; 2014: 135013. DOI: 10.1155/2014/135013
33. Ломоносова Е.В., Гольбиц А.Б., Рубцова Н.А., Алексеев Б.Я., Каприн А.Д. Перфузионная компьютерная томография в диагностике заболеваний почек (обзор литературы). Медицинская визуализация. 2023; 27 (2): 85-98. DOI: 10.24835/1607-0763-1220
Lomonosova E.V., Golbits A.B., Rubtsova N.A. et al. Application of perfusion computed tomography in renal diseases (review of literature). Medical Visualization. 2023; 27 (2): 85-98. (In Russian). DOI: 10.24835/1607-0763-1220
34. Fan A.C., Sundaram V., Kino A. et al. Early Changes in CT Perfusion Parameters: Primary Renal Carcinoma Versus Metastases After Treatment with Targeted Therapy. Cancers (Basel). 2019; 11 (5): 608. DOI: 10.3390/cancers11050608
35. Vehabovic-Delic A., Balic M., Rossmann C. et al. Volume Computed Tomography Perfusion Imaging: Evaluation of the Significance in Oncologic Follow-up of Metastasizing Renal Cell Carcinoma in the Early Period of Targeted Therapy - Preliminary Results. J.Comput. Assist. Tomogr. 2019; 43 (3): 493-498. 10.1097/ RCT. 0000000000000848. DOI: 10.1097/RCT.0000000000000848
36. Nielsen T.K., 0straat 0., Graumann O. et al.Computed Tomography Perfusion, Magnetic Resonance Imaging, and Histopathological Findings After Laparoscopic Renal Cryoablation: An In Vivo Pig Model. Technol. Cancer Res. Treat. 2017; 16 (4): 406-413. DOI: 10.1177/1533034616657251
37. Squillaci E., Manenti G., Ciccio C. et al. Perfusion-CT monitoring of cryo-ablated renal cells tumors. J. Exp. Clin. Cancer Res. 2009; 28 (1): 138. DOI: 10.1186/1756-9966-28-138
38. Zhang Z., Cen C., Qian K. et al. Assessment of the embolization effect of temperature-sensitive p (N-isopropylacrylamide-co-butyl methylacrylate) nanogels in the rabbit renal artery by CT perfusion and confirmed by macroscopic examination. Sci. Rep. 2021; 11 (1): 4826. DOI: 10.1038/s41598-021-84372-w
39. Александрова К.А., Серова Н.С., Руденко В.И., Газимиев М.А., Капанадзе Л.Б., Фиев Д.Н., Мискарян Т.И. Клиническое значение КТ-перфузии у пациентов с камнями мочеточника. Урология. 2019; 5: 38-43. DOI: 10.18565/urology.2019.5.38-43
Aleksandrova K.A., Serova N.S., Rudenko V.I. et al. Clinical value of CT-perfusion in patients with ureteric stones. Urologia. 2019; 5: 38-43. 10.18565/ urology.2019.5.38-43 (In Russian). DOI: 10.18565/urology.2019.5.38-43
40. Александрова К.А., Серова Н.С., Руденко В.И., Капанадзе Л.Б. Оценка перфузии почек у больных мочекаменной болезнью с помощью методов лучевой диагностики. Российский электронный журнал лучевой диагностики. 2018; 8 (4) 208-219. DOI: 10.21569/2222-7415-2018-8-4-208-219
Aleksandrova K.A., Serova N.S., Rudenko V.I., Kapanadze L.B. Assessment of kidney perfusion in patients with urolithiasis using radiological methods. REJR. 2018; 8 (4) 208-219. (In Russian).